ID: ALA5192181

Max Phase: Preclinical

Molecular Formula: C35H48N7O8P

Molecular Weight: 725.78

Associated Items:

Representations

Canonical SMILES:  CC(C)C(NC(=O)[C@@H]1C[C@@H](n2nncc2C(N)=O)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)P(=O)(Oc1ccccc1)Oc1ccccc1

Standard InChI:  InChI=1S/C35H48N7O8P/c1-22(2)31(51(47,49-24-15-11-9-12-16-24)50-25-17-13-10-14-18-25)39-30(44)26-19-23(42-27(29(36)43)20-37-40-42)21-41(26)32(45)28(34(3,4)5)38-33(46)48-35(6,7)8/h9-18,20,22-23,26,28,31H,19,21H2,1-8H3,(H2,36,43)(H,38,46)(H,39,44)/t23-,26+,28-,31?/m1/s1

Standard InChI Key:  HMIWVKCNBCTMKL-DDMOSAHQSA-N

Associated Targets(Human)

Leukocyte elastase 8173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEp-2 3859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chlamydia pecorum 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Chlamydia trachomatis 699 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 725.78Molecular Weight (Monoisotopic): 725.3302AlogP: 4.91#Rotatable Bonds: 12
Polar Surface Area: 197.07Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.52CX Basic pKa: CX LogP: 3.69CX LogD: 3.69
Aromatic Rings: 3Heavy Atoms: 51QED Weighted: 0.22Np Likeness Score: -0.47

References

1. Hwang J, Strange N, Mazraani R, Phillips MJ, Gamble AB, Huston WM, Tyndall JDA..  (2022)  Design, synthesis and biological evaluation of P2-modified proline analogues targeting the HtrA serine protease in Chlamydia.,  230  [PMID:35007862] [10.1016/j.ejmech.2021.114064]

Source